Immunome (IMNM) Leases (2023 - 2025)
Immunome (IMNM) has disclosed Leases for 3 consecutive years, with $3.0 million as the latest value for Q4 2025.
- For the quarter ending Q4 2025, Leases fell 30.39% year-over-year to $3.0 million, compared with a TTM value of $3.0 million through Dec 2025, down 30.39%, and an annual FY2025 reading of $3.0 million, down 30.39% over the prior year.
- Leases was $3.0 million for Q4 2025 at Immunome, down from $3.1 million in the prior quarter.
- Across five years, Leases topped out at $4.3 million in Q4 2024 and bottomed at $174000.0 in Q2 2023.
- Average Leases over 3 years is $2.3 million, with a median of $2.5 million recorded in 2024.
- The sharpest move saw Leases surged 1350.0% in 2024, then plummeted 30.39% in 2025.
- Year by year, Leases stood at $1.6 million in 2023, then skyrocketed by 173.53% to $4.3 million in 2024, then tumbled by 30.39% to $3.0 million in 2025.
- Business Quant data shows Leases for IMNM at $3.0 million in Q4 2025, $3.1 million in Q3 2025, and $3.3 million in Q2 2025.